MedTrace Logo

Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

NCT00873366 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2018-01-23

Study results available
· View outcomes & findings →

Summary

RATIONALE: A breath test that measures enzymes may be effective in identifying women in whom tamoxifen may not be effective.

PURPOSE: This clinical trial is studying a breath test to see how well it works in women receiving tamoxifen for the prevention or treatment of breast cancer.

Conditions

Interventions

DRUG

dextromethorphan hydrobromide

DRUG

tamoxifen citrate

OTHER

high performance liquid chromatography

OTHER

laboratory biomarker analysis

OTHER

pharmacogenomic studies

OTHER

pharmacological study

PROCEDURE

fluorescence imaging

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Matthew P. Goetz, M.D. · Mayo Clinic

  • Donald W. Northfelt, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2015-09-23
Completion
2015-09-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00873366 on ClinicalTrials.gov